Expiry of Unlisted Options
Updated : 13:00
22 September 2020
Kore Potash Plc
("Kore Potash" or the "Company")
Expiry of Unlisted Options and Change in Director's Interest Notice
The Company wishes to advise that 4,000,000 unlisted options exercisable at £0.11 each expired unexercised on 27 June 2020.
Included is a copy of a change in director's interest notice for Mr Hathorn, the Company's Chairman, who held these unlisted options.
The Company notes the lodgement of the above is outside the time prescribed by the ASX listing rules. The late lodgement was due to an administrative oversight. The Company and Mr Hathorn is aware of the requirements under ASX Listing Rules 3.19A and 3.19B. The administrative oversight has not affected the Company's current arrangement for ensuring timely notification in accordance with the listing rules.
The below change in director's interest notice also reflects the issue of 58,719,906 fully paid ordinary shares to Mr Hathorn following shareholder approval at the Company's recently held General Meeting.
ENDS
For further information, please visit www.korepotash.com or contact:
Kore Potash Brad Sampson - CEO
| Tel: +27 11 469 9140 | |
Tavistock Communications Jos Simson Edward Lee
| Tel: +44 (0) 20 7920 3150 | |
Canaccord Genuity - Nomad and Broker James Asensio Henry Fitzgerald-O'Connor
| Tel: +44 (0) 20 7523 4600 | |
Shore Capital - Joint Broker Jerry Keen Toby Gibbs Mark Percy | Tel: +44 (0) 20 7408 4050 |
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of Entity | Kore Potash Plc (ASX, AIM, JSE : KP2) |
ARBN | 621 843 614 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | David Andrew Hathorn |
Date of Last Notice | 7 April 2020 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Direct and Indirect |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Theseus (Guernsey) Limited as Trustee of the Belle Terre Trust (A Trust that the Director is a beneficiary of)
Theseus (Guernsey) Limited as Trustee of the Stapleford Trust (A Trust that the Director is a beneficiary of) |
Date of change | 21 September 2020 |
No. of securities held prior to change
54,457,146 Fully Paid Ordinary Shares (AIM Listed)
250,000 Equity Warrants exercisable at AUD 0.30 each expiring on 29 March 2021
500,000 Performance Rights each expiring 22 May 2022
4,000,000 Unlisted Options exercisable at £0.11 each expiring on 27 June 2020 | Held in the name of
Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)
Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)
Direct
Direct |
Class | Unlisted Options and Fully Paid Ordinary Shares (AIM) |
Number acquired | 58,719,906 Fully Paid Ordinary Shares (AIM) |
Number disposed | 4,000,000 Unlisted Options exercisable at £0.11 each expiring on 27 June 2020 (expired unexercised) |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | £0.0065 per Share |
No. of securities held after change
54,457,146 Fully Paid Ordinary Shares (AIM Listed)
250,000 Equity Warrants exercisable at AUD 0.30 each expiring on 29 March 2021
29,359,953 Fully Paid Ordinary Shares (AIM Listed)
29,359,953 Fully Paid Ordinary Shares (AIM Listed)
500,000 Performance Rights each expiring 22 May 2022 | Held in the name of
Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)
Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)
Theseus (Guernsey) Limited as Trustee of the Belle Terre Trust (A Trust that the Director is a beneficiary of)
Theseus (Guernsey) Limited as Trustee of the Stapleford Trust (A Trust that the Director is a beneficiary of)
Direct |
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | (i) Participation in Placement as approved at the Company's General Meeting on 18 September 2020 (refer to Resolution 3) (ii) Expiry of Unlisted Options |
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
Interest after change | N/A |
Part 3 - +Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? | N/A |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.